AdamsInmed has been stagnate and trending down for 3 years. They have no substantive news of their own that would lead to any share price appreciation.
Usually companies - even if they are small and unproven - will move with their sector due to the law of association (as we saw with Inmed in early 2018).
Once a company decouples from its sector mates and no longer moves in association, that is usually indicative of a systemic and problematic issue within the company. The "market" has a way of identifying this and treating the company accordingly.
This is what we are seeing with Inmed. Adams very well could be a very nice guy, but he is woefully failing as Inmed's CEO. The pace at which this company is progressing is excruciatingly slow. In June, he will have been CEO for 5 years. 5 Years and the sp is trading basically where it was when he took over in 2016. This is unacceptable under any circumstances but for Inmed to be in a sector (which arguably will be the biggest and most important we have seen in decades) is unforgivable.
#timetoreplaceadams